Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-519,885
Closed -$5.14M 1023
2022
Q2
$5.14M Hold
519,885
0.05% 270
2022
Q1
$5.14M Buy
519,885
+262,000
+102% +$2.58M 0.06% 231
2021
Q4
$2.56M Buy
257,885
+6,906
+3% +$68.4K 0.02% 451
2021
Q3
$2.5M Buy
250,979
+200,979
+402% +$1.98M 0.02% 457
2021
Q2
$506K Buy
+50,000
New +$506K ﹤0.01% 616

Other funds holding AKLI

UBS O'Connor's AKLI Position: Q3 2022 in Review

UBS O'Connor sold out of Akili Inc (AKLI) in Q3 2022, closing a stake of 519,885 shares — an estimated $5.14M sold.

UBS O'Connor first reported a position in AKLI in Q2 2021 and held it in 5 quarters. The position peaked at $5.14M in Q2 2022. 25 funds tracked by Wall St. Rank hold AKLI as of Q3 2022.

  • UBS O'Connor reported no remaining Akili Inc position as of Q3 2022 after selling out during the quarter.
  • UBS O'Connor sold 519,885 Akili Inc shares in Q3 2022, an estimated $5.14M.
  • UBS O'Connor first reported a position in Akili Inc in Q2 2021 and held it in 5 quarters.
  • UBS O'Connor's Akili Inc position peaked at $5.14M in Q2 2022.
  • 25 funds tracked by Wall St. Rank held Akili Inc as of Q3 2022.

Based on UBS O'Connor's 13F filing for Q3 2022, filed 14 Nov 2022.